Bumper Offer - Urjas oil Just @ Rs. 1
Rifarex 400 Mg Tablet, a prescription drug, is manufactured in various forms such as Tablet. It is primarily used for the treatment of Hepatic Encephalopathy. The alternative uses of Rifarex 400 Mg Tablet have also been explained below.
The optimal dosage of Rifarex 400 Mg Tablet is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Rifarex 400 Mg Tablet also has some side effects, the most common being Flatulence, Bloating or fullness, Constipation. Besides the aforementioned side effects, there are other adverse effects of Rifarex 400 Mg Tablet as well, which are listed below. Usually, these side effects of Rifarex 400 Mg Tablet go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Rifarex 400 Mg Tablet's effect during pregnancy is Severe and Severe while nursing. Warnings related to Rifarex 400 Mg Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Some other conditions that can be affected by Rifarex 400 Mg Tablet are listed in the contraindications section below.
Besides this, Rifarex 400 Mg Tablet may also have severe interaction with some medicines. A complete list of these interactions is given below.
You should also be aware that Rifarex 400 Mg Tablet is safe while driving, and is addiction.
Rifarex 400 Mg Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| 13 - 18 years (Adolescent) |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Rifarex 400 Mg Tablet is used -
Moderate
Mild
Common
Is the use of Rifarex 400 Mg Tablet safe for pregnant women?
Rifarex has many dangerous side effects in pregnant women. If you are pregnant, do not consume Rifarex without medical advice.
Is the use of Rifarex 400 Mg Tablet safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Rifarex. It should only be taken after medical advice.
What is the effect of Rifarex 400 Mg Tablet on the Kidneys?
There are no side effects of Rifarex on the kidneys.
What is the effect of Rifarex 400 Mg Tablet on the Liver?
Rifarex is rarely harmful for the liver.
What is the effect of Rifarex 400 Mg Tablet on the Heart?
Rifarex is not harmful for the heart.
Rifarex 400 Mg Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Rifarex 400 Mg Tablet unless your doctor advises you to do so -
Is this Rifarex 400 Mg Tablet habit forming or addictive?
Forming a habit of Rifarex 400 Mg Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Rifarex 400 Mg Tablet since it will not make you feel sleepy.
Is it safe?
Yes, but consume Rifarex 400 Mg Tablet only on doctor's advice.
Is it able to treat mental disorders?
No, Rifarex 400 Mg Tablet is not used to treat mental disorders.
Interaction between Food and Rifarex 400 Mg Tablet
You can take Rifarex 400 Mg Tablet with food.
Interaction between Alcohol and Rifarex 400 Mg Tablet
It is difficult to say anything about the effect of Rifarex 400 Mg Tablet and alcohol. No research has been done on this yet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xifaxan® (rifaximin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 681-683
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1096-1097
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xifaxan® (rifaximin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 681-683
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1096-1097
